From: Epidemiology, clinical features, and management of severe hypercalcemia in critically ill patients
All (n = 131) | Hemopathy (n = 58) | Solid tumors (n = 29) | Endocrinopathies (n = 16) | Other (n = 28) | |
---|---|---|---|---|---|
Clinical data | |||||
Age (y) | 58.5 [48.5; 69] | 58 [42; 67] | 63 [52; 68] | 52 [36.5; 67.25] | 66 [55.25; 74.25] |
Women, n (%) | 64 (48.8) | 22 (38) | 17 (58.6) | 9 (56) | 16 (57.1) |
Chronic kidney disease, n (%) | 25 (19.5) | 10 (17.2) | 2 (6.8) | 4 (25) | 10 (35.7) |
Cardiopathy, n (%) | 32 (25) | 8 (13.7) | 6 (20.7) | 4 (25) | 15 (53.5) |
SOFA score at day 1 | 2 [1, 4] | 4 [2, 5] | 1 [1, 3] | 1 [0; 2] | 2 [1, 3] |
SAPS II score at day 1 | 29.5 [22; 36.75] | 34 [28, 40] | 33 [24, 37] | 19.5 [16.75; 29.25] | 27 [18.5; 33] |
ECOG/WHO scale score | 1 [0; 3] | 1 [0; 2] | 3 [1, 3] | 0.5 [0; 2.75] | 1 [0; 3] |
Charlson score | 4 [2, 6] | 3 [2, 4] | 7 [6, 9] | 3 [1, 6] | 4 [2; 6.25] |
Admission diagnosis in ICU | |||||
Hypercalcemia, n (%) | 101 (77.1) | 42 (72.4) | 22 (76) | 13 (81) | 23 (82) |
Coma, delirium, n (%) | 9 (6.8) | 3 (5.2) | 5 (17.2) | 0 | 1 (3.5) |
Acute respiratory failure, n (%) | 5 (3.8) | 4 (6.8) | 1 (3.4) | 0 | 0 |
Tumor lysis syndrome, n (%) | 4 (3) | 4 (6.8) | 0 | 0 | 0 |
Acute kidney injury, n (%) | 4 (3) | 2 (3.4) | 1 (3.4) | 0 | 1 (3.5) |
Sepsis, n (%) | 5 (3.8) | 1 (1.7) | 0 | 3 (19) | 1 (3.5) |
Other, n (%) | 3 (2.2) | 2 (3.4) | 0 | 0 | 2 (7) |